Russian Journal of Genetics

, Volume 53, Issue 6, pp 640–650 | Cite as

Clinical and genetic characteristics and diagnostic features of Landouzy–Dejerine facioscapulohumeral muscular dystrophy

  • N. V. Zernov
  • A. V. Marakhonov
  • J. V. Vyakhireva
  • A. A. Guskova
  • E. L. Dadali
  • M. Yu. SkoblovEmail author
Reviews and Theoretical Articles


Landouzy–Dejerine facioscapulohumeral muscular dystrophy (FSHD) is one of the most common hereditary myodystrophies. A study of the genetic nature of the disease, which has an autosomal dominant mode of inheritance, is extremely interesting and revealing. A unique structure of D4Z4 macrosatellite repeats found in the 4q35 region was originally characterized by a decrease in the number of repeats in patients with Landouzy–Dejerine muscular dystrophy, which resulted in the activation of neighboring genes, in particular, the DUX4 transcription factor. Later, it was found that the epigenetic mechanisms responsible for the chromatin condensation of this region underlie the activation. To date, additional participants leading to pathogenesis of the disease, such as SMCHD1 methylation regulator and DBE-T regulatory long noncoding RNA, have been identified. The revealed complexity of the disease mechanisms is in good agreement with the observed pattern of the disease inheritance. The study of the Landouzy–Dejerine muscular dystrophy pathogenesis is a good example of how monogenic diseases can possess a more complex nature of inheritance.


Landouzy–Dejerine muscular dystrophy pathogenesis of the disease DNA diagnostics 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Padberg, G.W., Frants, R.R., Brouwer, O.F., et al., Facioscapulohumeral muscular dystrophy in the Dutch population, Muscle Nerve Suppl., 1995, vol. 2, pp. S81–S84.CrossRefPubMedGoogle Scholar
  2. 2.
    Flanigan, K.M., Coffeen, C.M., Sexton, L., et al., Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy, Neuromuscular Disord., 2001, vol. 11, nos. 6–7, pp. 525–529.CrossRefGoogle Scholar
  3. 3.
    Mostacciuolo, M.L., Pastorello, E., Vazza, G., et al., Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample, Clin. Genet., 2009, vol. 75, no. 6, pp. 550–555. doi 10.1111/j.1399-0004.2009.01158.xCrossRefPubMedGoogle Scholar
  4. 4.
    Norwood, F.L., Harling, C., Chinnery, P.F., et al., Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population, Brain, 2009, vol. 132, no. 11, pp. 3175–3186. doi 10.1093/brain/awp236CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Zatz, M., Marie, S.K., Passos-Bueno, M.R., et al., High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families, Am. J. Hum. Genet., 1995, vol. 56, no. 1, pp. 99–105.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Bakker, E., Wijmenga, C., Vossen, R.H., et al., The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter, Muscle Nerve Suppl., 1995, vol. 2, pp. S39–S44.CrossRefPubMedGoogle Scholar
  7. 7.
    Landouzy, L. and Dejerine, J., De la myopathie atrophique progressive; myopathie héréditaire, sans neuropathie, debutant d’ordinaire dans l’enfance par la face, Paris: F. Alcan, 1885.Google Scholar
  8. 8.
    Padberg, G., Facioscapulohumeral Disease, Leiden: Univ. Leiden, 1982.Google Scholar
  9. 9.
    Tawil, R., Storvick, D., Feasby, T.E., et al., Extreme variability of expression in monozygotic twins with FSH muscular dystrophy, Neurology, 1993, vol. 43, no. 2, pp. 345–348.CrossRefPubMedGoogle Scholar
  10. 10.
    Padberg, G.W., Facioscapulohumeral muscular dystrophy: a clinician’s experience, in Facioscapulohumeral Muscular Dystrophy (FSHD): Clinical Medicine and Molecular Cell Biology, London: Garland Science, 2004, pp. 41–51.Google Scholar
  11. 11.
    Tawil, R., Facioscapulohumeral muscular dystrophy, Neurotherapeutics, 2008, vol. 5, no. 4, pp. 601–606. doi 10.1016/j.nurt.2008.07.005CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Quarantelli, M., Lanzillo, R., Del Vecchio, W., et al., Modifications of brain tissue volumes in facioscapulohumeral dystrophy, Neuroimage, 2006, vol. 32, no. 3, pp. 1237–1242. doi 10.1016/j.neuroimage.2006.04.226CrossRefPubMedGoogle Scholar
  13. 13.
    Arahata, K., Ishihara, T., Fukunaga, H., et al., Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses, Muscle Nerve Suppl., 1995, vol. 2, pp. S56–S66.Google Scholar
  14. 14.
    Frisullo, G., Frusciante, R., Nociti, V., et al., CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI, J. Clin. Immunol., 2011, vol. 31, no. 2, pp. 155–166. doi 10.1007/s10875-010-9474-6CrossRefPubMedGoogle Scholar
  15. 15.
    Papa, S., Guerrieri, F., Zanotti, F., et al., F0 and F1 subunits involved in the gate and coupling function of mitochondrial H+ ATP synthase, Ann. N.Y. Acad. Sci., 1992, vol. 671, pp. 345–358.CrossRefPubMedGoogle Scholar
  16. 16.
    Upadhyaya, M., Lunt, P.W., Sarfarazi, M., et al., DNA marker applicable to presymptomatic and prenatal diagnosis of facioscapulohumeral disease, Lancet, 1990, vol. 336, no. 8726, pp. 1320–1321.CrossRefPubMedGoogle Scholar
  17. 17.
    Wijmenga, C., Frants, R.R., Brouwer, O.F., et al., Location of facioscapulohumeral muscular dystrophy gene on chromosome 4, Lancet, 1990, vol. 336, no. 8716, pp. 651–653.CrossRefPubMedGoogle Scholar
  18. 18.
    Wijmenga, C., Padberg, G.W., Moerer, P., et al., Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization, Genomics, 1991, vol. 9, no. 4, pp. 570–575.CrossRefPubMedGoogle Scholar
  19. 19.
    Mathews, K.D., Mills, K.A., Bosch, E.P., et al., Linkage localization of facioscapulohumeral muscular dystrophy (FSHD) in 4q35, Am. J. Hum. Genet., 1992, vol. 51, no. 2, pp. 428–431.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Upadhyaya, M., Lunt, P., Sarfarazi, M., et al., The mapping of chromosome 4q markers in relation to facioscapulohumeral muscular dystrophy (FSHD), Am. J. Hum. Genet., 1992, vol. 51, no. 2, pp. 404–410.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Wijmenga, C., Hewitt, J.E., Sandkuijl, L.A., et al., Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy, Nat. Genet., 1992, vol. 2, no. 1, pp. 26–30. doi 10.1038/ng0992-26CrossRefPubMedGoogle Scholar
  22. 22.
    Gabriels, J., Beckers, M.C., Ding, H., et al., Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element, Gene, 1999, vol. 236, no. 1, pp. 25–32.CrossRefPubMedGoogle Scholar
  23. 23.
    Deidda, G., Cacurri, S., Grisanti, P., et al., Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter, Eur. J. Hum. Genet., 1995, vol. 3, no. 3, pp. 155–167.PubMedGoogle Scholar
  24. 24.
    Butz, M., Koch, M.C., Muller-Felber, W., et al., Facioscapulohumeral muscular dystrophy: phenotypegenotype correlation in patients with borderline D4Z4 repeat numbers, J. Neurol., 2003, vol. 250, no. 8, pp. 932–937. doi 10.1007/s00415-003-1116-yCrossRefPubMedGoogle Scholar
  25. 25.
    Lunt, P.W., 44th ENMC International Workshop: Facioscapulohumeral Muscular Dystrophy: Molecular Studies 19–21 July 1996, Naarden, The Netherlands, Neuromuscular Disord., 1998, vol. 8, no. 2, pp. 126–130.CrossRefGoogle Scholar
  26. 26.
    Bakker, E., Wijmenga, C., Vossen, R.H., et al., The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter, Muscle Nerve Suppl., 1995, vol. 2, pp. S39–S44.CrossRefPubMedGoogle Scholar
  27. 27.
    Lemmers, R.J., van der Maarel, S.M., van Deutekom, J.C., et al., Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis, Hum. Mol. Genet., 1998, vol. 7, no. 8, pp. 1207–1214.CrossRefPubMedGoogle Scholar
  28. 28.
    Lemmers, R.J., Wohlgemuth, M., van der Gaag, K.J., et al., Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy, Am. J. Hum. Genet., 2007, vol. 81, no. 5, pp. 884–894. doi 10.1086/521986CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Lemmers, R.J., van der Vliet, P.J., van der Gaag, K.J., et al., Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution, Am. J. Hum. Genet., 2010, vol. 86, no. 3, pp. 364–377. doi 10.1016/j.ajhg.2010.01.035CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Wijmenga, C., Frants, R.R., Hewitt, J.E., et al., Molecular genetics of facioscapulohumeral muscular dystrophy, Neuromuscular Disord., 1993, vol. 3, nos. 5–6, pp. 487–491.CrossRefGoogle Scholar
  31. 31.
    Tupler, R., Berardinelli, A., Barbierato, L., et al., Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy, J. Med. Genet., 1996, vol. 33, no. 5, pp. 366–370.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Hewitt, J.E., Lyle, R., Clark, L.N., et al., Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy, Hum. Mol. Genet., 1994, vol. 3, no. 8, pp. 1287–1295.CrossRefPubMedGoogle Scholar
  33. 33.
    Snider, L., Asawachaicharn, A., Tyler, A.E., et al., RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy, Hum. Mol. Genet., 2009, vol. 18, no. 13, pp. 2414–2430. doi 10.1093/hmg/ddp180CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Dixit, M., Ansseau, E., Tassin, A., et al., DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1, Proc. Natl. Acad. Sci. U.S.A., 2007, vol. 104, no. 46, pp. 18157–18162. doi 10.1073/pnas.0708659104CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    van Geel, M., Dickson, M.C., Beck, A.F., et al., Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin, Genomics, 2002, vol. 79, no. 2, pp. 210–217. doi 10.1006/geno. 2002.6690CrossRefPubMedGoogle Scholar
  36. 36.
    Lejeune, E. and Allshire, R.C., Common ground: small RNA programming and chromatin modifications, Curr. Opin. Cell. Biol., 2011, vol. 23, no. 3, pp. 258–265. doi 10.1016/ Scholar
  37. 37.
    Pal-Bhadra, M., Leibovitch, B.A., Gandhi, S.G., et al., Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery, Science, 2004, vol. 303, no. 5658, pp. 669–672. doi 10.1126/science.1092653CrossRefPubMedGoogle Scholar
  38. 38.
    Probst, A.V., Okamoto, I., Casanova, M., et al., A strand-specific burst in transcription of pericentric satellites is required for chromocenter formation and early mouse development, Dev. Cell, 2010, vol. 19, no. 4, pp. 625–638. doi 10.1016/j.devcel.2010.09.002CrossRefPubMedGoogle Scholar
  39. 39.
    Sabin, L.R., Delas, M.J., and Hannon, G.J., Dogma derailed: the many influences of RNA on the genome, Mol Cell, 2013, vol. 49, no. 5, pp. 783–794. doi 10.1016/j.molcel.2013.02.010CrossRefPubMedGoogle Scholar
  40. 40.
    Volpe, T.A., Kidner, C., Hall, I.M., et al., Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi, Science, 2002, vol. 297, no. 5588, pp. 1833–1837. doi 10.1126/science.1074973CrossRefPubMedGoogle Scholar
  41. 41.
    Snider, L., Geng, L.N., Lemmers, R.J., et al., Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene, PLoS Genet., 2010, vol. 6, no. 10. e1001181. doi 10.1371/journal.pgen.1001181CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Cabianca, D.S., Casa, V., Bodega, B., et al., A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy, Cell, 2012, vol. 149, no. 4, pp. 819–831. doi 10.1016/j.cell.2012.03.035CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Gregory, G.D., Vakoc, C.R., Rozovskaia, T., et al., Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes, Mol. Cell. Biol., 2007, vol. 27, no. 24, pp. 8466–8479. doi 10.1128/MCB.00993-07CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Tanaka, Y., Katagiri, Z., Kawahashi, K., et al., Trithorax- group protein ASH1 methylates histone H3 lysine 36, Gene, 2007, vol. 397, nos. 1–2, pp. 161–168. doi 10.1016/j.gene.2007.04.027CrossRefPubMedGoogle Scholar
  45. 45.
    Yuan, W., Xu, M., Huang, C., et al., H3K36 methylation antagonizes PRC2-mediated H3K27 methylation, J. Biol. Chem., 2011, vol. 286, no. 10, pp. 7983–7989. doi 10.1074/jbc.M110.194027CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., et al., DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?. J. Cell. Mol. Med., 2013, vol. 17, no. 1, pp. 76–89. doi 10.1111/j.1582-4934.2012.01647.xCrossRefPubMedGoogle Scholar
  47. 47.
    Bourque, G., Leong, B., Vega, V.B., et al., Evolution of the mammalian transcription factor binding repertoire via transposable elements, Genome Res., 2008, vol. 18, no. 11, pp. 1752–1762. doi 10.1101/gr.080663.108CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Leidenroth, A. and Hewitt, J.E., A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene, BMC Evol. Biol., 2010, vol. 10, p. 364. doi 10.1186/1471-2148-10- 364CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    van Overveld, P.G., Lemmers, R.J., Sandkuijl, L.A., et al., Hypomethylation of D4Z4 in 4q-linked and non- 4q-linked facioscapulohumeral muscular dystrophy, Nat. Genet., 2003, vol. 35, no. 4, pp. 315–317. doi 10.1038/ng1262CrossRefPubMedGoogle Scholar
  50. 50.
    de Greef, J.C., Lemmers, R.J., van Engelen, B.G., et al., Common epigenetic changes of D4Z4 in contraction- dependent and contraction-independent FSHD, Hum. Mutat., 2009, vol. 30, no. 10, pp. 1449–1459. doi 10.1002/humu.21091CrossRefPubMedGoogle Scholar
  51. 51.
    Zeng, W., de Greef, J.C., Chen, Y.Y., et al., Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD), PLoS Genet., 2009, vol. 5, no. 7. e1000559. doi 10.1371/journal.pgen.1000559CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Balog, J., Thijssen, P.E., de Greef, J.C., et al., Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD, Epigenetics, 2012, vol. 7, no. 6, pp. 579–584. doi 10.4161/epi.20001CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Kowaljow, V., Marcowycz, A., Ansseau, E., et al., The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein, Neuromuscular Disord., 2007, vol. 17, no. 8, pp. 611–623. doi 10.1016/j.nmd.2007.04.002CrossRefGoogle Scholar
  54. 54.
    Wallace, L.M., Garwick, S.E., Mei, W., et al., DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo, Ann. Neurol., 2011, vol. 69, no. 3, pp. 540–552. doi 10.1002/ana.22275CrossRefPubMedGoogle Scholar
  55. 55.
    Lemmers, R.J., Tawil, R., Petek, L.M., et al., Digenic inheritance of an SMCHD1 mutation and an FSHDpermissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2, Nat. Genet., 2012, vol. 44, no. 12, pp. 1370–1374. doi 10.1038/ng.2454CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Blewitt, M.E., Gendrel, A.V., Pang, Z., et al., SmcHD1, containing a structural-maintenance-ofchromosomes hinge domain, has a critical role in X inactivation, Nat. Genet., 2008, vol. 40, no. 5, pp. 663–669. doi 10.1038/ng.142CrossRefPubMedGoogle Scholar
  57. 57.
    Gendrel, A.V., Apedaile, A., Coker, H., et al., Smchd1- dependent and-independent pathways determine developmental dynamics of CpG island methylation on the inactive X chromosome, Dev. Cell, 2012, vol. 23, no. 2, pp. 265–279. doi 10.1016/j.devcel.2012.06.011CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Gendrel, A.V., Tang, Y.A., Suzuki, M., et al., Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes, Mol. Cell. Biol., 2013, vol. 33, no. 16, pp. 3150–3165. doi 10.1128/MCB.00145-13CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Mould, A.W., Pang, Z., Pakusch, M., et al., Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation, Epigenet. Chromatin, 2013, vol. 6, no. 1, pp. 19. doi 10.1186/1756-8935-6-19CrossRefGoogle Scholar
  60. 60.
    Larsen, M., Rost, S., El Hajj, N., et al., Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1, Eur. J. Hum. Genet., 2015, vol. 23, no. 6, pp. 808–816. doi 10.1038/ejhg.2014.191CrossRefPubMedGoogle Scholar
  61. 61.
    Lunt, P.W., Compston, D.A., and Harper, P.S., Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias, J. Med. Genet., 1989, vol. 26, no. 12, pp. 755–760.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Scionti, I., Greco, F., Ricci, G., et al., Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy, Am. J. Hum. Genet., 2012, vol. 90, no. 4, pp. 628–635. doi 10.1016/j.ajhg.2012.02.019CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Statland, J.M., McDermott, M.P., Heatwole, C., et al., Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy, Neuromuscular Disord., 2013, vol. 23, no. 4, pp. 306–312. doi 10.1016/j.nmd.2013.01.008CrossRefGoogle Scholar
  64. 64.
    The FSH-DY Group, A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials, Neurology, 1997, vol. 48, no. 1, pp. 38–46.CrossRefGoogle Scholar
  65. 65.
    Busse, K., Kohler, J., Stegmann, K., et al., An inherited 4q35-EcoRI-DNA-fragment of 35 kb in a family with a sporadic case of facioscapulohumeral muscular dystrophy (FSHD), Neuromuscular Disord., 2000, vol. 10, no. 3, pp. 178–181.CrossRefGoogle Scholar
  66. 66.
    Tsumagari, K., Chen, D., Hackman, J.R., et al., FSH dystrophy and a subtelomeric 4q haplotype: a new assay and associations with disease, J. Med. Genet., 2010, vol. 47, no. 11, pp. 745–751. doi 10.1136/jmg.2009.076703CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    de Greef, J.C., Frants, R.R., and van der Maarel, S.M., Epigenetic mechanisms of facioscapulohumeral muscular dystrophy, Mutat. Res., 2008, vol. 647, nos. 1–2, pp. 94–102. doi 10.1016/j.mrfmmm.2008.07.011CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Jones, T.I., Yan, C., Sapp, P.C., et al., Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing, Clin. Epigenet., 2014, vol. 6, no. 1, p. 23. doi 10.1186/1868-7083-6-23CrossRefGoogle Scholar
  69. 69.
    Nguyen, K., Walrafen, P., Bernard, R., et al., Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy, Ann. Neurol., 2011, vol. 70, no. 4, pp. 627–633. doi 10.1002/ana.22513CrossRefPubMedGoogle Scholar
  70. 70.
    Vasale, J., Boyar, F., Jocson, M., et al., Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD, Neuromuscular Disord., 2015, vol. 25, no. 12, pp. 945–951. doi 10.1016/j.nmd. 2015.08.008CrossRefGoogle Scholar
  71. 71.
    Newlands, S., Levitt, L.K., Robinson, C.S., et al., Transcription occurs in pulses in muscle fibers, Genes Dev., 1998, vol. 12, no. 17, pp. 2748–2758.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Pleiades Publishing, Inc. 2017

Authors and Affiliations

  • N. V. Zernov
    • 1
  • A. V. Marakhonov
    • 1
    • 3
  • J. V. Vyakhireva
    • 1
  • A. A. Guskova
    • 1
  • E. L. Dadali
    • 1
  • M. Yu. Skoblov
    • 1
    • 2
    • 3
    Email author
  1. 1.Research Centre of Medical GeneticsMoscowRussia
  2. 2.Evdokimov Moscow State University of Medicine and DentistryMoscowRussia
  3. 3.Moscow Institute of Physics and TechnologyDolgoprudny, Moscow oblastRussia

Personalised recommendations